Anglo American Platinum has posted an adjusted EBITDA of R12.3 billion

Loading player...
GUEST – Craig Miller, CEO of Anglo American Platinum

Highlights
Stringent safety measures implemented to prevent recurrence of two tragic fatalities and improve safety.
Refined PGM production up 5% in H1 2024 to 1.78 million ounces compared to the prior period, while metal-in-concentrate down 5% to 1.76 million ounces
Sales volumes increased 9%, due to draw down of inventory.
R12.3 billion EBITDA, down 8% on the prior period, despite a 24% decline in realised PGM dollar basket prices to $1,442, inflation and once-off restructuring costs, which were partially offset by cost reductions and higher sales.
On track to meet R10 billion capital expenditure and cost out target for 2024, with ~R4.7 billion of savings in H1 2024, of which ~R2.9 billion were operating costs and ~R1.8 billion stay in business capital.
Achieved an all-in sustaining cost (AISC) of $957 per 3E ounce, well ahead of the 2024 target of below ~$1,050; on track to sustain cash generation through a low PGM price cycle.
Restructuring progressing at pace, with statutory employee consultation complete and Mortimer Smelter on care and maintenance from end of April 2024
Strong net cash position of R14.5 billion, including the customer prepayment
Interim dividend of R2.6 billion, or R9.75 per share, equivalent to 40% payout of headline earnings in line with capital allocation framewo
22 Jul 2024 2PM English South Africa Business News · Investing

Other recent episodes

Why Women’s Financial Empowerment Is an Economic Multiplier

Women’s financial empowerment has the potential to drive economic growth, strengthen households and create lasting generational wealth. Kaya Biz speaks to Alexandra Nortier, Joint Head of Wealth Management at Investec Wealth & Investment International, about why Investec is backing the JSE SheInvests 2026 initiative, the barriers keeping women out of…
23 Jul 1PM 7 min

Affordable Diabetes Care Arrives in SA with Novo Nordisk

Novo Nordisk South Africa GM Sara Norcross explains the launch of the country’s only authorised copy of semaglutide, manufactured using the identical API, process and device as the originator — but at a more affordable price. We unpack what an authorised copy is, why SAHPRA registration matters, how the Acino…
23 Jul 1PM 14 min

SARB holds rates steady in July MPC – What It Means for You

Momentum economist Tshiamo Masike unpacks the SARB’s decision to pause, the upside inflation surprise, and the global factors driving the MPC’s decision. We explore how rising oil prices, geopolitical tensions, and weakening consumer confidence shaped the call — and what households, businesses and markets should expect next. A sharp, data‑driven…
23 Jul 1PM 14 min

PIC Board Exodus: Khaya Sithole on SA’s Biggest Asset Manager in Crisis

Six PIC directors have resigned, Treasury has begun steps to remove others, and whistleblower allegations of interference are mounting. Independent analyst Khaya Sithole breaks down the governance crisis unfolding at the Public Investment Corporation, what’s driving the board exodus, and what this means for the R2.5 trillion in assets the…
22 Jul 1PM 14 min

SA July MPC preview: Rates Outlook amid Hot Inflation

With inflation rising to 5.0%, fuel prices surging, and administered costs climbing, the SARB’s Monetary Policy Committee faces a tough call. Sanlam Investments economist Patrick Buthelezi unpacks today’s CPI print, the risks driving inflation, and what to expect from tomorrow’s MPC meeting. Essential listening for anyone watching interest rates and…
22 Jul 1PM 15 min